1-3 of 3
Andreas Feldges
Close
Sort by
Journal Articles

Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95

Clinical Trials & Observations
Anja Möricke, Alfred Reiter, Martin Zimmermann, Helmut Gadner, Martin Stanulla, Michael Dördelmann, Lutz Löning, Rita Beier, Wolf-Dieter Ludwig, Richard Ratei, Jochen Harbott, Joachim Boos, Georg Mann, Felix Niggli, Andreas Feldges, Günter Henze, Karl Welte, Jörn-Dirk Beck, Thomas Klingebiel, Charlotte Niemeyer, Felix Zintl, Udo Bode, Christian Urban, Helmut Wehinger, Dietrich Niethammer, Hansjörg Riehm, Martin Schrappe
Journal: Blood
Blood (2008) 111 (9): 4477–4489.
https://doi.org/10.1182/blood-2007-09-112920
Published: 2008
Includes: Supplemental data
Journal Articles

Increased Lipoprotein(a) levels are not a steady prothrombotic defect

Wolfgang Korte, Jeanette Greiner, Andreas Feldges, Walter F. Riesen
Journal: Blood
Blood (2001) 98 (6): 1993–1994.
https://doi.org/10.1182/blood.V98.6.1993
Published: 2001
Journal Articles

Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90

Clinical Trials & Observations
Martin Schrappe, Alfred Reiter, Wolf-Dieter Ludwig, Jochen Harbott, Martin Zimmermann, Wolfgang Hiddemann, Charlotte Niemeyer, Günter Henze, Andreas Feldges, Felix Zintl, Bernhard Kornhuber, Jörg Ritter, Karl Welte, Helmut Gadner, Hansjörg Riehm
Journal: Blood
Blood (2000) 95 (11): 3310–3322.
https://doi.org/10.1182/blood.V95.11.3310
Published: 2000